{"Cases": [0], "of": [1, 21, 25, 41, 46, 93, 128, 145, 147], "severe": [2], "acute": [3], "respiratory": [4], "syndrome": [5], "coronavirus": [6], "2": [7], "(SARS-CoV-2)": [8], "infection": [9, 123, 132], "in": [10, 14, 28, 56], "Manaus,": [11], "Brazil,": [12], "resurged": [13], "late": [15], "2020": [16, 32, 86], "despite": [17], "previously": [18], "high": [19], "levels": [20], "infection.": [22], "Genome": [23], "sequencing": [24], "viruses": [26], "sampled": [27], "Manaus": [29], "between": [30], "November": [31], "and": [33, 39, 62, 87, 105, 119], "January": [34], "2021": [35], "revealed": [36], "the": [37, 57, 69, 129], "emergence": [38, 82], "circulation": [40], "a": [42, 54, 91, 98], "novel": [43], "SARS-CoV-2": [44], "variant": [45], "concern.": [47], "Lineage": [48], "P.1": [49, 81, 111, 134], "acquired": [50], "17": [51], "mutations,": [52], "including": [53], "trio": [55], "spike": [58], "protein": [59], "(K417T,": [60], "E484K,": [61], "N501Y)": [63], "associated": [64], "with": [65, 133], "increased": [66, 152], "binding": [67], "to": [68, 115, 126, 159], "human": [70], "ACE2": [71], "(angiotensin-converting": [72], "enzyme": [73], "2)": [74], "receptor.": [75], "Molecular": [76], "clock": [77], "analysis": [78], "shows": [79], "that": [80, 102, 110, 120, 135], "occurred": [83], "around": [84], "mid-November": [85], "was": [88], "preceded": [89], "by": [90], "period": [92], "faster": [94], "molecular": [95], "evolution.": [96], "Using": [97], "two-category": [99], "dynamical": [100], "model": [101], "integrates": [103], "genomic": [104, 143], "mortality": [106], "data,": [107], "we": [108], "estimate": [109], "may": [112, 150], "be": [113], "1.7-": [114], "2.4-fold": [116], "more": [117], "transmissible": [118], "previous": [121], "(non-P.1)": [122], "provides": [124, 137], "54": [125], "79%": [127], "protection": [130], "against": [131, 138], "it": [136], "non-P.1": [139], "lineages.": [140], "Enhanced": [141], "global": [142], "surveillance": [144], "variants": [146], "concern,": [148], "which": [149], "exhibit": [151], "transmissibility": [153], "and/or": [154], "immune": [155], "evasion,": [156], "is": [157], "critical": [158], "accelerate": [160], "pandemic": [161], "responsiveness.": [162]}